Works matching IS 15268209 AND DT 2023 AND VI 23 AND IP 2


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8

    Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.

    Published in:
    Clinical Breast Cancer, 2023, v. 23, n. 2, p. 155, doi. 10.1016/j.clbc.2022.11.005
    By:
    • Choucair, Khalil;
    • Page, Seth J.;
    • Mattar, Bassam I.;
    • Dakhil, Christopher S.;
    • Nabbout, Nassim H.;
    • Deutsch, Jeremy M.;
    • Truong, Quoc V.;
    • Truong, Phu V.;
    • Moore, Dennis F.;
    • Cannon, Michael W.;
    • James Kallail, K.;
    • Moore, Joseph A.;
    • Dakhil, Shaker R.;
    • Diab, Radwan;
    • Kamran, Syed;
    • Reddy, Pavan S.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14